Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04543877Phase 1Completed
Phase 1, randomised trial (2 arms), sponsored by Western Human Nutrition Research Center. Primary endpoint: Change in vaccine-specific antibody-secreting cell response to oral Ty21a typhoid vaccination at Day 39. Started Sep 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04543877.